Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edward M Scolnick

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Molecular Psychiatry|March 9, 2022
The schizophrenia-associated variant in SLC39A8 alters protein glycosylation in the mouse brainRobert G Mealer, Sarah E Williams, Maxence Noel, et al.
Scientific Reports|August 6, 2020
The schizophrenia risk locus in SLC39A8 alters brain metal transport and plasma glycosylationRobert G Mealer, Bruce G Jenkins, Chia-Yen Chen, et al.
Chemistry & Biology|August 2, 2011
AAK1 identified as an inhibitor of neuregulin-1/ErbB4-dependent neurotrophic factor signaling using integrative chemical genomics and proteomicsLetian Kuai, Shao-En Ong, Jon M Madison, et al.
Neuron|March 31, 2005
Regulation of gene expression by lithium and depletion of inositol in slices of adult rat cortexPhilip E Brandish, Ming Su, Daniel J Holder, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|March 11, 2011
AKT kinase activity is required for lithium to modulate mood-related behaviors in miceJen Q Pan, Michael C Lewis, Josh K Ketterman, et al.
Science Translational Medicine|May 22, 2020
Selective inhibition of glycogen synthase kinase 3α corrects pathophysiology in a mouse model of fragile X syndromePatrick K McCamphill, Laura J Stoppel, Rebecca K Senter, et al.
Bioorganic & Medicinal Chemistry Letters|December 13, 2005
The discovery of a potent and selective lethal factor inhibitor for adjunct therapy of anthrax infectionYusheng Xiong, Judyann Wiltsie, Andrea Woods, et al.
Iscience|January 7, 2021
Regulation of purine metabolism connects KCTD13 to a metabolic disorder with autistic featuresJon M Madison, Karen Duong, Ellen F Vieux, et al.
Biological Psychiatry|October 4, 2002
Developing novel treatments for mood disorders: accelerating discoveryCarol A Tamminga, Charles B Nemeroff, Randy D Blakely, et al.
Annals of the New York Academy of Sciences|October 29, 2011
Advancing drug discovery for schizophreniaStephen R Marder, Bryan Roth, Patrick F Sullivan, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Molecular Psychiatry|March 9, 2022
The schizophrenia-associated variant in SLC39A8 alters protein glycosylation in the mouse brainRobert G Mealer, Sarah E Williams, Maxence Noel, et al.
Scientific Reports|August 6, 2020
The schizophrenia risk locus in SLC39A8 alters brain metal transport and plasma glycosylationRobert G Mealer, Bruce G Jenkins, Chia-Yen Chen, et al.
Chemistry & Biology|August 2, 2011
AAK1 identified as an inhibitor of neuregulin-1/ErbB4-dependent neurotrophic factor signaling using integrative chemical genomics and proteomicsLetian Kuai, Shao-En Ong, Jon M Madison, et al.
Neuron|March 31, 2005
Regulation of gene expression by lithium and depletion of inositol in slices of adult rat cortexPhilip E Brandish, Ming Su, Daniel J Holder, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|March 11, 2011
AKT kinase activity is required for lithium to modulate mood-related behaviors in miceJen Q Pan, Michael C Lewis, Josh K Ketterman, et al.
Science Translational Medicine|May 22, 2020
Selective inhibition of glycogen synthase kinase 3α corrects pathophysiology in a mouse model of fragile X syndromePatrick K McCamphill, Laura J Stoppel, Rebecca K Senter, et al.
Bioorganic & Medicinal Chemistry Letters|December 13, 2005
The discovery of a potent and selective lethal factor inhibitor for adjunct therapy of anthrax infectionYusheng Xiong, Judyann Wiltsie, Andrea Woods, et al.
Iscience|January 7, 2021
Regulation of purine metabolism connects KCTD13 to a metabolic disorder with autistic featuresJon M Madison, Karen Duong, Ellen F Vieux, et al.
Biological Psychiatry|October 4, 2002
Developing novel treatments for mood disorders: accelerating discoveryCarol A Tamminga, Charles B Nemeroff, Randy D Blakely, et al.
Annals of the New York Academy of Sciences|October 29, 2011
Advancing drug discovery for schizophreniaStephen R Marder, Bryan Roth, Patrick F Sullivan, et al.
Pageof 4